Receiver Operator Characteristics (ROC) curve analysis of plasma HO-1 levels from TB patients at week 20 of antibubercular therapy was performed to test the performance of this marker in discriminating individuals who were successfully treated (negative sputum cultures and no symptoms) from those who underwent treatment failure or subsequently relapsed (see Methods for clinical details). HO-1 cut-off value used for the ROC inferential analysis was >11.5 ng/mL. AUC, area under the curve. with TAT-conjugated NRF-2 sequence peptide that interacts with the Keap-1/NRF-2 complex (TAT-14, 50µM). Bars and lines represent mean and SEM, respectively. Data are from at least three independent experiments using triplicate biological samples. Data were compared using the Wilcoxon matched-pairs test. ***p<0.0001, NS, nonsignificant.
